Drug profile · INN
estradiol valerate
DELESTROGEN
estradiol valerate (DELESTROGEN) is a estrogen receptor alpha agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — estradiol valerate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
estradiol valerate (DELESTROGEN) is a estrogen receptor alpha agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor alpha agonist
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is estradiol valerate?
estradiol valerate (DELESTROGEN) is a estrogen receptor alpha agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for estradiol valerate?
DELESTROGEN is a marketed brand name for estradiol valerate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of estradiol valerate?
estradiol valerate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.